News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

Friday, October 31, 2014

Top Breaking News
IMPAX Laboratories, Inc. (IPXL) Sacks 25% Of R&D Staff In Reorg
Novartis AG (NVS) Quietly Leases Large Space In Philadelphia
Novartis AG (NVS) Eliminates Another 75 Jobs
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR)
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark
Hundreds Of New Jobs Coming To Virginia As UniTao Pharma Snaps Up Boehringer Ingelheim Corporation's Old Plant
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs
SF's Billion Dollar Biotech FibroGen, Inc. Sets Terms For $124 Million IPO
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch
SF Startup Imago BioSciences Reels In $26.5 Million
AVANIR Pharmaceuticals (AVNR) Gives Suitors Two Big Reasons To Bid
FDA Panel Backs Daiichi Sankyo, Inc. (4568.t)'s New A-Fib Drug Savaysa
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant
Oragenics, Inc. (OGEN) CEO Resigns; Hunt For New Chief Begins

Featured Stories

More News
Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) To Be PBS Listed For Metastatic Pancreatic Cancer
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Pivotal Phase 3 Results From AVP-825 Acute Migraine Study In The Journal "Headache"
OptiNose AS Announces Publication Of Pivotal Phase 3 Results For Investigational Migraine Treatment Developed By Optinose Using Bi-Directional™ Breath Powered™ Technology
Medivation, Inc. (MDVN) And Astellas Pharma US Announce Phase 3 Study Of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy
Onxeo: Positive Phase 2 Preliminary Results Of Validive® For The Prevention Of Severe Oral Mucositis In Head And Neck Cancer Patients
BioLineRx Ltd. Reports Publication In Peer Review Journal Of Results From Previous Phase 1/2 Trial For BCM (BL-1040), A Novel Medical Device For Prevention Of Cardiac Remodeling Following Acute Myocardial Infarction
Xcovery Presents Phase 1 Results Of X-396 In ALK Positive NSCLC At The 2014 Multidisciplinary Symposium In Thoracic Oncology
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib
Kaiser Permanente Release: Digoxin Associated With Higher Risk Of Death And Hospitalization In Adults With Atrial Fibrillation And No Heart Failure
Paratek Pharmaceuticals, Inc. Completes Merger With Transcept Pharmaceuticals, Inc. (TSPT)
Sterigenics International, Inc. Continues Growth With Acquisition Of Leading Italian Sterilization Firm
Medidata Solutions, Inc. Selected By ASLAN Pharmaceuticals As Enterprise-Wide Technology Platform For Enhancing Clinical Development
Zogenix, Inc. (ZGNX) And Purdue Pharma L.P. Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products
Partnership Pays: Collaboration Among Case Western Reserve University, Cuyahoga County, And YMCA of Greater Cleveland Catalyzes More Than $13 Million In Public Health Grants
Migranade, Inc. Release: Game Changing Migraine Medication To Be Available November 2014
AmnioLife Files U.S. Patent Application
Dyadic International, Inc. Extends All Convertible Debt Maturity Dates
Chimerix, Inc. (CMRX) Prices Public Offering Of Common Stock
Discovery Laboratories (DSCO) Announces Organizational Change And Enhanced Expertise In Neonatology
Cellectis (ALCLS): Event Report: Individual Shareholders’ Meeting Held On October 23, 2014
The Medicines Company (MDCO) To Webcast Investor & Analyst Day On November 5
Royal Phillips Electronics Lifeline GoSafe Mobile Technology Keeps Seniors Connected To Emergency Care On-The-Go
Cirrus Pharmaceuticals, Inc., A Kemwell Company, To Invest In cGMP Manufacturing Suite In U.S.
PuriCore Interim Management Statement
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST)
CEN Biotech Releases Health Canada Pre-License Inspection Report
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR
AbbVie (ABBV) Reports Third-Quarter 2014 Financial Results
Asterias Biotherapeutics To Report Third Quarter Results On November 10, 2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Third-Quarter 2014 Financial Results
Anacor Pharmaceuticals, Inc. (ANAC) Announces Third Quarter 2014 Financial Results Conference Call And Webcast
Agenus (AGEN) Reports Third Quarter 2014 Financial Results
BioTie Therapies Corp. Interim Report 1 January - 30 September 2014
Capricor Therapeutics, Inc. To Hold Third Quarter 2014 Business Update Conference Call On November 12, 2014 At 4:30 P.M. ET
Dyadic International, Inc. To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014
Fibrocell Science, Inc. To Report Third Quarter 2014 Financial And Operating Results, And Host Conference Call And Webcast On November 7, 2014
Affymetrix (Bedford, Massachusetts) (AFFX) Reports Third Quarter 2014 Operating Results
Fluidigm Corporation Reports Q3 2014 Results
GlycoMimetics, Inc. (GLYC) Reports Third Quarter 2014 Results
Hyperion Therapeutics (HPTX) To Report Third Quarter 2014 Financial Results After Market On November 6, 2014
Intercept Pharmaceuticals (ICPT) To Report Third Quarter 2014 Results On November 7 And Present At Upcoming Conferences
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' Third Quarter 2014 Financial Results Conference Call
IRIDEX Corporation (IRIX) Reports 2014 Third Quarter, Nine-Month Results
Insmed Incorporated (INSM) To Host Third Quarter 2014 Financial Results Conference Call On Thursday, November 6, 2014
MWI Veterinary Supply Announces Its Fiscal Year 2014 Earnings Release Date And Conference Call Information
Lonza Group Ltd. (LZAGY.PK)’s Overall Business Performance Year-to-Date On Track
Mast Therapeutics (MSTX) Reports Third Quarter 2014 Financial Results
Mylan Inc. (MYL) Third Quarter 2014 Adjusted Diluted EPS Increases 41% To $1.16
NeoStem, Inc. Announces Third Quarter 2014 Financial Results And Outlines Near Term Milestones
OncoGenex Pharmaceuticals Inc. (OGXI) Reports Financial Results For Third Quarter 2014
Omnicell Announces Third Quarter 2014 Results
Pain Therapeutics (PTIE) Reports Q3 2014 Financial Results
Provectus Biopharmaceuticals Inc. To Hold Quarterly Conference Call On Thursday, November 6, 2014
PerkinElmer, Inc. (PKI) Announces Financial Results For The Third Quarter Of 2014
Retrophin (RTRX) To Report Third Quarter 2014 Financial Results
Regulus Therapeutics, Inc. (RGLS) Announces Timing For Third Quarter 2014 Financial Results Webcast And Conference Call
Rockwell Medical (RMTI) Schedules Third Quarter 2014 Investor Conference Call
Synageva BioPharma (GEVA) Reports Third Quarter 2014 Financial Results
Seattle Genetics, Inc. (SGEN) Reports Third Quarter 2014 Financial Results
Theravance Biopharma, Inc. To Report Third Quarter 2014 Financial Results On November 6, 2014
Theravance, Inc. (THRX) Reports Third Quarter 2014 Financial Results
Vital Therapies, Inc. (VTI) (VTL) Announces Third Quarter 2014 Financial Results Conference Call With Webcast And Upcoming Conference Presentation
West Announces Third Quarter 2014 Results
ZIOPHARM Oncology, Inc. (ZIOP.OB) Reports Third-Quarter 2014 Financial Results
Zogenix, Inc. (ZGNX) Announces Conference Call And Webcast To Present Third Quarter 2014 Financial Results
Quinterol Mallette Appointed To GenVec Inc. (GNVC) Board Of Directors
Eminent Immuno-Oncologist, Dr. Wayne Hancock, Joins Progenra, Inc.’S Scientific Advisory Board
Visterra, Inc. Announces Additions To Its Management Team And Board Of Directors
TraceLink Life Sciences Cloud Selected By Pharmasphere To Ensure Drug Supply Chain Security Act (DSCSA) Compliance
Inovio Pharmaceuticals (INO)' CEO Dr. J. Joseph Kim Interviewed By The Life Sciences Report
Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms
Henry Schein, Inc. (HSIC)'s Think Pink, Practice Pink Program Donates More Than $173,000 To Organizations Supporting Cancer-Related Causes In 2014
International GPCR Consortium Includes China Academic Members
Clinical Ink Ranked Second Fastest-Growing Company On Philadelphia 100® List
Emory University To Join The National Parkinson Foundation Center Of Excellence Network
Eisai Inc. (ESALF.PK) Release: Lorcaserin Data To Be Presented At The Obesity Society's Annual Scientific Meeting
Lycera Announces Presentation Of Data On Anti-Tumor Activity Of Novel Synthetic RORgamma Agonists At Society For Immunotherapy Of Cancer Meeting
CSL Behring Release: Evidence Presented At The 16th Biennial Meeting Of The European Society For Immunodeficiencies (ESID) Supports Individualized Dosing With Hizentra®
Eisai Inc. (ESALF.PK) Relase: Lorcaserin Data To Be Presented At The Obesity Society's Annual Scientific Meeting
Alnylam Pharmaceuticals (ALNY) To Webcast Presentation At The Nomura Biotechnology Conference
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Investor Conferences In November 2014
Celgene (CELG) To Webcast At Upcoming Investor Conferences And Medical Congress
NephroGenex (NRX) To Participate In Two Healthcare Conferences In November
Akebia Therapeutics, Inc. (AKBA) To Participate In Upcoming Investor Conferences
ZS Pharma (ZSPH) Announces Multiple Presentations From ZS003, A Phase 3 Trial Of ZS-9, At The American Society of Nephrology Annual Meeting
Orexigen Therapeutics, Inc. (OREX) Announces Contrave® (naltrexone HCI And Bupropion HCI Extended Release) Data Presentations At The ObesityWeek Meeting In Boston
CPhI Worldwide 2014 Announces Biggest Ever Show And Points To Pharma Growth In Brazil, Russia And Fast Emerging Africa
Blackstone NC Sponsoring 16th Annual Southeast Biotechnology Industry Organization (BIO) Investor & Partnering Forum
Vertex Pharmaceuticals Incorporated (VRTX) To Present At The Credit Suisse Healthcare Conference On November 11
Centene Corporation To Present At Credit Suisse 2014 Healthcare Conference

//-->